Ajanta Pharma to add liquid formulation facility at Pithampur site
Mumbai: Ajanta Pharma has announced an expansion of its manufacturing capabilities by adding a state-of-the-art liquid formulation facility at its Pithampur site.
The move is part of the company's strategy to meet the rising global demand for its liquid formulations.
The new facility will add a capacity of 12 million bottles per annum on a single-shift basis. Currently, Ajanta Pharma’s Pithampur plant operates at a capacity of 6 million bottles annually on a single-shift basis.
The expansion entails an investment of Rs 92 crore and is scheduled to be completed in the first quarter of FY26, the company stated in a BSE filing.
Read also: Ajanta Pharma Sets a Record with India's Largest Photo Collage of CPR Workshops
Ajanta Pharma is a speciality pharmaceutical formulation company having major focus on branded generic business across India, Asia & Africa. The company has a ground presence in each of these 30+ countries.
The company’s state-of-the-art R&D centre is located in Mumbai. The company has 7 world-class manufacturing facilities located in India. For the last 5 financial years, the company has posted healthy performance with its Revenue from Operations growing at 16% CAGR and net profit at 11% CAGR.
Read also: Ajanta Pharma Gets CDSCO panel conditional Nod to Manufacture, Market Cardiovascular FDC Drug
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.